Abstract
Neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and multiple sclerosis are characterized by a chronic and selective process of neuronal cell death. Although the causes of neurodegenerative diseases remain still unknown, it is now a well-established idea that more factors, such as genetic, endogenous, and environmental, are involved. Among environmental causes, the accumulation of mercury, a heavy metal considered a toxic agent, was largely studied as a probable factor involved in neurodegenerative disease course. Mercury exists in three main forms: elemental mercury, inorganic mercury, and organic mercury (methylmercury and ethylmercury). Sources of elemental mercury can be natural (volcanic emission) or anthropogenic (coal-fired electric utilities, waste combustion, hazardous-waste incinerators, and gold extraction). Moreover, mercury is still used as an antiseptic, as a medical preservative, and as a fungicide. Dental amalgam can emit mercury vapor. Mercury vapor, being highly volatile and lipid soluble, can cross the blood-brain barrier and the lipid cell membranes and can be accumulated into the cells in its inorganic forms. Also, methylmercury can pass through blood-brain and placental barriers, causing serious damage in the central nervous system. This review describes the toxic effects of mercury in cell cultures, in animal models, and in patients with neurodegenerative diseases. In vitro experiments showed that mercury exposure was principally involved in oxidative stress and apoptotic processes. Moreover, motor and cognitive impairment and neural loss have been confirmed in various studies performed in animal models. Finally, observational studies on patients with neurodegenerative diseases showed discordant data about a possible mercury involvement.
Similar content being viewed by others
References
El Haj M, Roche J, Gallouj K, Gandolphe MC (2017) Autobiographical memory compromise in Alzheimer’s disease: a cognitive and clinical overview. Geriatrie et Psychologie Neuropsychiatrie du Vieillissement 15(4):443–451. https://doi.org/10.1684/pnv.2017.0704
Alves G, Wentzel-Larsen T, Aarsland D, Larsen JP (2005) Progression of motor impairment and disability in Parkinson disease: a population-based study. Neurology 65(9):1436–1441. https://doi.org/10.1212/01.wnl.0000183359.50822.f2
Yang Y, Tang BS, Guo JF (2016) Parkinson’s disease and cognitive impairment. Park Dis 2016:6734678. https://doi.org/10.1155/2016/6734678
Raggi A, Covelli V, Schiavolin S, Scaratti C, Leonardi M, Willems M (2016) Work-related problems in multiple sclerosis: a literature review on its associates and determinants. Disabil Rehabil 38(10):936–944. https://doi.org/10.3109/09638288.2015.1070295
Tsuang DW, Bird TD (2017) Genetic factors in neurodegenerative diseases. Am J Med Genet Part B, Neuropsychiatr Genet: Off Publ Int Soc Psychiatr Genet 174(1):3–4. https://doi.org/10.1002/ajmg.b.32504
Monnet-Tschudi F, Zurich MG, Boschat C, Corbaz A, Honegger P (2006) Involvement of environmental mercury and lead in the etiology of neurodegenerative diseases. Rev Environ Health 21(2):105–117
Mutter J, Naumann J, Sadaghiani C, Schneider R, Walach H (2004) Alzheimer disease: mercury as pathogenetic factor and apolipoprotein E as a moderator. Neuro Endocrinol Lett 25(5):331–339
Allen Reish HE, Standaert DG (2015) Role of alpha-synuclein in inducing innate and adaptive immunity in Parkinson disease. J Park Dis 5(1):1–19. https://doi.org/10.3233/JPD-140491
Zheng M, Shi Y, Fan D (2013) Nuclear TAR DNA-binding protein 43: a new target for amyotrophic lateral sclerosis treatment. Neural Regen Res 8(35):3284–3295. https://doi.org/10.3969/j.issn.1673-5374.2013.35.003
Ramanan VK, Saykin AJ (2013) Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer’s disease, Parkinson’s disease, and related disorders. Am J Neurodegenerative Dis 2(3):145–175
Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443(7113):787–795. https://doi.org/10.1038/nature05292
Liang P, Le W (2015) Role of autophagy in the pathogenesis of multiple sclerosis. Neurosci Bull 31(4):435–444. https://doi.org/10.1007/s12264-015-1545-5
Rivera-Mancia S, Perez-Neri I, Rios C, Tristan-Lopez L, Rivera-Espinosa L, Montes S (2010) The transition metals copper and iron in neurodegenerative diseases. Chem Biol Interact 186(2):184–199. https://doi.org/10.1016/j.cbi.2010.04.010
Gaeta A, Hider RC (2005) The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy. Br J Pharmacol 146(8):1041–1059. https://doi.org/10.1038/sj.bjp.0706416
Carocci A, Rovito N, Sinicropi MS, Genchi G (2014) Mercury toxicity and neurodegenerative effects. Rev Environ Contam Toxicol 229:1–18. https://doi.org/10.1007/978-3-319-03777-6_1
Fung YK, Meade AG, Rack EP, Blotcky AJ (1997) Brain mercury in neurodegenerative disorders. J Toxicol Clin Toxicol 35(1):49–54
Clarkson TW, Magos L (2006) The toxicology of mercury and its chemical compounds. Crit Rev Toxicol 36(8):609–662. https://doi.org/10.1080/10408440600845619
Magos L, Clarkson TW (2006) Overview of the clinical toxicity of mercury. Ann Clin Biochem 43:257–268. https://doi.org/10.1258/000456306777695654
Harada M (1995) Minamata disease: methylmercury poisoning in Japan caused by environmental pollution. Crit Rev Toxicol 25(1):1–24. https://doi.org/10.3109/10408449509089885
Skerfving SB, Copplestone JF (1976) Poisoning caused by the consumption of organomercury-dressed seed in Iraq. Bull World Health Organ 54(1):101–112
Xu F, Farkas S, Kortbeek S, Zhang FX, Chen L, Zamponi GW, Syed NI (2012) Mercury-induced toxicity of rat cortical neurons is mediated through N-methyl-D-aspartate receptors. Mol Brain 5:30. https://doi.org/10.1186/1756-6606-5-30
Kim SH, Johnson VJ, Sharma RP (2002) Mercury inhibits nitric oxide production but activates proinflammatory cytokine expression in murine macrophage: differential modulation of NF-kappaB and p38 MAPK signaling pathways. Nitric Oxide Biol Chem 7(1):67–74
Ortega HG, Lopez M, Takaki A, Huang QH, Arimura A, Salvaggio JE (1997) Neuroimmunological effects of exposure to methylmercury forms in the Sprague-Dawley rats. Activation of the hypothalamic-pituitary-adrenal axis and lymphocyte responsiveness. Toxicol Ind Health 13(1):57–66
Havarinasab S, Bjorn E, Nielsen JB, Hultman P (2007) Mercury species in lymphoid and non-lymphoid tissues after exposure to methyl mercury: correlation with autoimmune parameters during and after treatment in susceptible mice. Toxicol Appl Pharmacol 221(1):21–28. https://doi.org/10.1016/j.taap.2007.02.009
Kim MK, Zoh KD (2012) Fate and transport of mercury in environmental media and human exposure. J Prev Med Publ Health = Yebang Uihakhoe chi 45(6):335–343. https://doi.org/10.3961/jpmph.2012.45.6.335
Yokoo EM, Valente JG, Grattan L, Schmidt SL, Platt I, Silbergeld EK (2003) Low level methylmercury exposure affects neuropsychological function in adults. Environ Health: Global Access Sci Source 2(1):8. https://doi.org/10.1186/1476-069X-2-8
Drasch G, Schupp I, Hofl H, Reinke R, Roider G (1994) Mercury burden of human fetal and infant tissues. Eur J Pediatr 153(8):607–610
Murcia M, Ballester F, Enning AM, Iniguez C, Valvi D, Basterrechea M, Rebagliato M, Vioque J, Maruri M, Tardon A, Riano-Galan I, Vrijheid M, Llop S (2016) Prenatal mercury exposure and birth outcomes. Environ Res 151:11–20. https://doi.org/10.1016/j.envres.2016.07.003
Prpic I, Milardovic A, Vlasic-Cicvaric I, Spiric Z, Nisevic JR, Vukelic P, Tratnik JS, Mazej D, Horvat M (2017) Prenatal exposure to low-level methylmercury alters the child’s fine motor skills at the age of 18 months. Environ Res 152:369–374. https://doi.org/10.1016/j.envres.2016.10.011
Castoldi AF, Barni S, Turin I, Gandini C, Manzo L (2000) Early acute necrosis, delayed apoptosis and cytoskeletal breakdown in cultured cerebellar granule neurons exposed to methylmercury. J Neurosci Res 59(6):775–787. https://doi.org/10.1002/(Sici)1097-4547(20000315)59:6<775::Aid-Jnr10>3.0.Co;2-T
Zahir F, Rizwi SJ, Haq SK, Khan RH (2005) Low dose mercury toxicity and human health. Environ Toxicol Pharmacol 20(2):351–360. https://doi.org/10.1016/j.etap.2005.03.007
Azevedo BF, Furieri LB, Pecanha FM, Wiggers GA, Vassallo PF, Simoes MR, Fiorim J, de Batista PR, Fioresi M, Rossoni L, Stefanon I, Alonso MJ, Salaices M, Vassallo DV (2012) Toxic effects of mercury on the cardiovascular and central nervous systems J Biomed Biotechnol doi:Artn 949,048 https://doi.org/10.1155/2012/949048
Clarkson TW (2002) The three modern faces of mercury. Environ Health Perspect 110(Suppl 1):11–23
Clarkson TW, Vyas JB, Ballatorl N (2007) Mechanisms of mercury disposition in the body. Am J Ind Med 50(10):757–764. https://doi.org/10.1002/ajim.20476
Pirrone N, Cinnirella S, Feng X, Finkelman RB, Friedli HR, Leaner J, Mason R, Mukherjee AB, Stracher GB, Streets DG, Telmer K (2010) Global mercury emissions to the atmosphere from anthropogenic and natural sources. Atmos Chem Phys 10(13):5951–5964. https://doi.org/10.5194/acp-10-5951-2010
Bose-O’Reilly S, Lettmeier B, Gothe RM, Beinhoff C, Siebert U, Drasch G (2008) Mercury as a serious health hazard for children in gold mining areas. Environ Res 107(1):89–97. https://doi.org/10.1016/j.envres.2008.01.009
Mutter J, Naumann J, Guethlin C (2007) Comments on the article “the toxicology of mercury and its chemical compounds” by Clarkson and Magos (2006). Crit Rev Toxicol 37(6):537–549; discussion 551–532. https://doi.org/10.1080/10408440701385770
Halbach S, Vogt S, Kohler W, Felgenhauer N, Welzl G, Kremers L, Zilker T, Melchart D (2008) Blood and urine mercury levels in adult amalgam patients of a randomized controlled trial: interaction of Hg species in erythrocytes. Environ Res 107(1):69–78. https://doi.org/10.1016/j.envres.2007.07.005
Rice KM, Walker EM Jr, Wu M, Gillette C, Blough ER (2014) Environmental mercury and its toxic effects. J Prev Med Publ Health = Yebang Uihakhoe chi 47(2):74–83. https://doi.org/10.3961/jpmph.2014.47.2.74
Mutter J, Curth A, Naumann J, Deth R, Walach H (2010) Does inorganic mercury play a role in Alzheimer’s disease? A systematic review and an integrated molecular mechanism. J Alzheim Dis 22(2):357–374. https://doi.org/10.3233/JAD-2010-100,705
Rooney JP (2007) The role of thiols, dithiols, nutritional factors and interacting ligands in the toxicology of mercury. Toxicology 234(3):145–156. https://doi.org/10.1016/j.tox.2007.02.016
Fonnum F, Lock EA (2004) The contributions of excitotoxicity, glutathione depletion and DNA repair in chemically induced injury to neurones: exemplified with toxic effects on cerebellar granule cells. J Neurochem 88(3):513–531
Albrecht J, Matyja E (1996) Glutamate: a potential mediator of inorganic mercury neurotoxicity. Metab Brain Dis 11(2):175–184
Hunter AM, Brown DL (2000) Effects of microtubule-associated protein (MAP) expression on methylmercury-induced microtubule disassembly. Toxicol Appl Pharmacol 166(3):203–213. https://doi.org/10.1006/taap.2000.8953
Huel G, Sahuquillo J, Debotte G, Oury JF, Takser L (2008) Hair mercury negatively correlates with calcium pump activity in human term newborns and their mothers at delivery. Environ Health Perspect 116(2):263–267. https://doi.org/10.1289/ehp.10381
Farina M, Rocha JB, Aschner M (2011) Mechanisms of methylmercury-induced neurotoxicity: evidence from experimental studies. Life Sci 89(15–16):555–563. https://doi.org/10.1016/j.lfs.2011.05.019
Ralston NV, Raymond LJ (2010) Dietary selenium’s protective effects against methylmercury toxicity. Toxicology 278(1):112–123. https://doi.org/10.1016/j.tox.2010.06.004
Farina M, Aschner M, Rocha JB (2011) Oxidative stress in MeHg-induced neurotoxicity. Toxicol Appl Pharmacol 256(3):405–417. https://doi.org/10.1016/j.taap.2011.05.001
Zahir F, Rizvi SJ, Haq SK, Khan RH (2006) Effect of methyl mercury induced free radical stress on nucleic acids and protein: implications on cognitive and motor functions. Indian J Clin Biochem: IJCB 21(2):149–152. https://doi.org/10.1007/BF02912931
Sinha K, Das J, Pal PB, Sil PC (2013) Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis. Arch Toxicol 87(7):1157–1180. https://doi.org/10.1007/s00204-013-1034-4
Collins Y, Chouchani ET, James AM, Menger KE, Cocheme HM, Murphy MP (2012) Mitochondrial redox signalling at a glance. J Cell Sci 125(4):801–806. https://doi.org/10.1242/jcs.098475
Murphy MP (2009) How mitochondria produce reactive oxygen species. Biochem J 417:1–13. https://doi.org/10.1042/Bj20081386
Kannan K, Jain SK (2000) Oxidative stress and apoptosis. Pathophysiol: Off J Int Soc Pathophysiol 7(3):153–163
LeBel CP, Ali SF, McKee M, Bondy SC (1990) Organometal-induced increases in oxygen reactive species: the potential of 2′,7′-dichlorofluorescin diacetate as an index of neurotoxic damage. Toxicol Appl Pharmacol 104(1):17–24
Parran DK, Mundy WR, Barone S Jr (2001) Effects of methylmercury and mercuric chloride on differentiation and cell viability in PC12 cells. Toxicoll Sci: Off J Soc Toxicol 59(2):278–290
Schubert J, Riley EJ, Tyler SA (1978) Combined effects in toxicology—a rapid systematic testing procedure: cadmium, mercury, and lead. J Toxicol Environ Health 4(5–6):763–776. https://doi.org/10.1080/15287397809529698
Papp A, Pecze L, Szabo A, Vezer T (2006) Effects on the central and peripheral nervous activity in rats elicited by acute administration of lead, mercury and manganese, and their combinations. J Appl Toxicol: JAT 26(4):374–380. https://doi.org/10.1002/jat.1152
Haley BE (2005) Mercury toxicity: genetic susceptibility and synergistic effects. Medical Veritas: The Journal of Medical Truth 2:535–542
Balmus IM, Strungaru SA, Ciobica A, Nicoara MN, Dobrin R, Plavan G, Stefanescu C (2017) Preliminary data on the interaction between some biometals and oxidative stress status in mild cognitive impairment and Alzheimer’s disease patients. Oxidative Med Cell Longev 2017:7156928. https://doi.org/10.1155/2017/7156928
Bjorkblom B, Adilbayeva A, Maple-Grodem J, Piston D, Okvist M, Xu XM, Brede C, Larsen JP, Moller SG (2013) Parkinson disease protein DJ-1 binds metals and protects against metal-induced cytotoxicity. J Biol Chem 288(31):22809–22,820. https://doi.org/10.1074/jbc.M113.482091
Liu S, Liu J, Wang XD, Shi Z, Zhou Y, Li J, Yu T, Ji Y (2017) Caregiver burden, sleep quality, depression, and anxiety in dementia caregivers: a comparison of frontotemporal lobar degeneration, dementia with Lewy bodies, and Alzheimer’s disease. Int Psychogeriatrics: 1–8. doi:https://doi.org/10.1017/S1041610217002630
Jomova K, Vondrakova D, Lawson M, Valko M (2010) Metals, oxidative stress and neurodegenerative disorders. Mol Cell Biochem 345(1–2):91–104. https://doi.org/10.1007/s11010-010-0563-x
Crespo AC, Silva B, Marques L, Marcelino E, Maruta C, Costa S, Timoteo A, Vilares A, Couto FS, Faustino P, Correia AP, Verdelho A, Porto G, Guerreiro M, Herrero A, Costa C, de Mendonca A, Costa L, Martins M (2014) Genetic and biochemical markers in patients with Alzheimer’s disease support a concerted systemic iron homeostasis dysregulation. Neurobiol Aging 35(4):777–785. https://doi.org/10.1016/j.neurobiolaging.2013.10.078
De Simone U, Caloni F, Gribaldo L, Coccini T (2017) Human co-culture model of neurons and astrocytes to test acute cytotoxicity of neurotoxic compounds. Int J Toxicol 36(6):463–477
Lu TH, Hsieh SY, Yen CC, Wu HC, Chen KL, Hung DZ, Chen CH, Wu CC, Su YC, Chen YW, Liu SH, Huang CF (2011) Involvement of oxidative stress-mediated ERK1/2 and p38 activation regulated mitochondria-dependent apoptotic signals in methylmercury-induced neuronal cell injury. Toxicol Lett 204(1):71–80. https://doi.org/10.1016/j.toxlet.2011.04.013
Olivieri G, Brack C, Muller-Spahn F, Stahelin HB, Herrmann M, Renard P, Brockhaus M, Hock C (2000) Mercury induces cell cytotoxicity and oxidative stress and increases beta-amyloid secretion and tau phosphorylation in SHSY5Y neuroblastoma cells. J Neurochem 74(1):231–236
Herrmann M, Golombowski S, Krauchi K, Frey P, Mourton-Gilles C, Hulette C, Rosenberg C, Muller-Spahn F, Hock C (1999) ELISA-quantitation of phosphorylated tau protein in the Alzheimer’s disease brain. Eur Neurol 42(4):205–210. https://doi.org/10.1159/000008108
Fujimura M, Usuki F, Sawada M, Takashima A (2009) Methylmercury induces neuropathological changes with tau hyperphosphorylation mainly through the activation of the c-jun-N-terminal kinase pathway in the cerebral cortex, but not in the hippocampus of the mouse brain. Neurotoxicology 30(6):1000–1007. https://doi.org/10.1016/j.neuro.2009.08.001
Gerhardsson L, Lundh T, Minthon L, Londos E (2008) Metal concentrations in plasma and cerebrospinal fluid in patients with Alzheimer’s disease. Dement Geriatr Cogn Disord 25(6):508–515. https://doi.org/10.1159/000129365
Hock C, Drasch G, Golombowski S, Muller-Spahn F, Willershausen-Zonnchen B, Schwarz P, Hock U, Growdon JH, Nitsch RM (1998) Increased blood mercury levels in patients with Alzheimer’s disease. J Neural Transm 105(1):59–68. https://doi.org/10.1007/s007020050038
Giacoppo S, Galuppo M, Calabro RS, D’Aleo G, Marra A, Sessa E, Bua DG, Potorti AG, Dugo G, Bramanti P, Mazzon E (2014) Heavy metals and neurodegenerative diseases: an observational study. Biol Trace Elem Res 161(2):151–160. https://doi.org/10.1007/s12011-014-0094-5
Harris FM, Tesseur I, Brecht WJ, Xu Q, Mullendorff K, Chang S, Wyss-Coray T, Mahley RW, Huang Y (2004) Astroglial regulation of apolipoprotein E expression in neuronal cells. Implications for Alzheimer’s disease. J Biol Chem 279(5):3862–3868. https://doi.org/10.1074/jbc.M309475200
Hendrie HC, Murrell J, Baiyewu O, Lane KA, Purnell C, Ogunniyi A, Unverzagt FW, Hall K, Callahan CM, Saykin AJ, Gureje O, Hake A, Foroud T, Gao S (2014) APOE ε4 and the risk for Alzheimer disease and cognitive decline in African Americans and Yoruba. Int Psychogeriatr 26(6):977–985. https://doi.org/10.1017/S1041610214000167
Godfrey ME, Wojcik DP, Krone CA (2003) Apolipoprotein E genotyping as a potential biomarker for mercury neurotoxicity. J Alzheimers Dis 5(3):189–195
Laws SM, Hone E, Gandy S, Martins RN (2003) Expanding the association between the APOE gene and the risk of Alzheimer’s disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription. J Neurochem 84(6):1215–1236. https://doi.org/10.1046/j.1471-4159.2003.01615.x
Pendergrass JC, Haley BE, Vimy MJ, Winfield SA, Lorscheider FL (1997) Mercury vapor inhalation inhibits binding of GTP to tubulin in rat brain: similarity to a molecular lesion in Alzheimer diseased brain. Neurotoxicology 18(2):315–324
Morris MC, Brockman J, Schneider JA, Wang Y, Bennett DA, Tangney CC, van de Rest O (2016) Association of seafood consumption, brain mercury level, and APOE ε4 status with brain neuropathology in older adults. JAMA 315(5):489–497. https://doi.org/10.1001/jama.2015.19451
Lee J-Y, Kim J-H, Choi D-W, Lee D-W, Park J-H, Yoon H-J, Pyo H-S, Kwon H-J, Park K-S (2012) The association of heavy metal of blood and serum in the Alzheimer’s diseases. Toxicol Res 28(2):93–98
Pamphlett R, Kum Jew S (2015) Different populations of human locus ceruleus neurons contain heavy metals or hyperphosphorylated tau: implications for amyloid-beta and tau pathology in Alzheimer’s disease. J Alzheimers Dis 45(2):437–447
Sun Y-H, Nfor ON, Huang J-Y, Liaw Y-P (2015) Association between dental amalgam fillings and Alzheimer’s disease: a population-based cross-sectional study in Taiwan. Alzheimers Res Ther 7(1):65
Park J-H, Lee D-W, Park KS, Joung H (2014) Serum trace metal levels in Alzheimer’s disease and normal control groups. Am J Alzheimers Dis Other Demen 29(1):76–83
Jadvar H, Colletti PM (2014) Competitive advantage of PET/MRI. Eur J Radiol 83(1):84–94. https://doi.org/10.1016/j.ejrad.2013.05.028
Zhang XY, Yang ZL, Lu GM, Yang GF, Zhang LJ (2017) PET/MR imaging: new frontier in Alzheimer’s disease and other dementias. Front Mol Neurosci 10:343. https://doi.org/10.3389/fnmol.2017.00343
Gallegos S, Pacheco C, Peters C, Opazo CM, Aguayo LG (2015) Features of alpha-synuclein that could explain the progression and irreversibility of Parkinson’s disease. Front Neurosci 9:59
Tysnes OB, Storstein A (2017) Epidemiology of Parkinson’s disease. J Neural Transm 124(8):901–905. https://doi.org/10.1007/s00702-017-1686-y
de Lau LM, Breteler MM (2006) Epidemiology of Parkinson’s disease. Lancet Neurol 5(6):525–535. https://doi.org/10.1016/S1474-4422(06)70471-9
Reeve A, Simcox E, Turnbull D (2014) Ageing and Parkinson’s disease: why is advancing age the biggest risk factor? Ageing Res Rev 14:19–30. https://doi.org/10.1016/j.arr.2014.01.004
Kuzis G, Sabe L, Tiberti C, Leiguarda R, Starkstein SE (1997) Cognitive functions in major depression and Parkinson disease. Arch Neurol 54(8):982–986
Goldman SM (2014) Environmental toxins and Parkinson’s disease. Annu Rev Pharmacol Toxicol 54:141–164. https://doi.org/10.1146/annurev-pharmtox-011613-135,937
Bjorklund G, Stejskal V, Urbina MA, Dadar M, Chirumbolo S, Mutter J (2017) Metals and Parkinson’s disease: mechanisms and biochemical processes. Curr Med Chem. https://doi.org/10.2174/0929867325666171129124616
Bjorklund G (1995) Parkinson disease, mercury and other heavy metals. Tidsskrift for den Norske laegeforening: tidsskrift for praktisk medicin, ny raekke 115(6):757
Forte G, Alimonti A, Pino A, Stanzione P, Brescianini S, Brusa L, Sancesario G, Violante N, Bocca B (2005) Metals and oxidative stress in patients with Parkinson’s disease. Annali dell’Istituto Superiore di Sanita 41(2):189–195
Dantzig PI (2006) Parkinson’s disease, macular degeneration and cutaneous signs of mercury toxicity. J Occup Environ Med 48(7):656. https://doi.org/10.1097/01.jom.0000228351.74230.52
Miller K, Ochudlo S, Opala G, Smolicha W, Siuda J (2003) Parkinsonism in chronic occupational metallic mercury intoxication. Neurologia Neurochirurgia Polska 37(Suppl 5):31–38
Hsu Y-C, Chang C-W, Lee H-L, Chuang C-C, Chiu H-C, Li W-Y, Horng J-T, Fu E (2016) Association between history of dental amalgam fillings and risk of Parkinson’s disease: a population-based retrospective cohort study in Taiwan. PLoS One 11(12):e0166552
Palacios N, Fitzgerald K, Roberts AL, Hart JE, Weisskopf MG, Schwarzschild MA, Ascherio A, Laden F (2014) A prospective analysis of airborne metal exposures and risk of Parkinson disease in the nurses’ health study cohort. Environ Health Perspect 122(9):933–938. https://doi.org/10.1289/ehp.1307218
Wijesekera LC, Leigh PN (2009) Amyotrophic lateral sclerosis. Orphanet J Rare Dis 4:3. https://doi.org/10.1186/1750-1172-4-3
Yamanaka K, Chun SJ, Boillee S, Fujimori-Tonou N, Yamashita H, Gutmann DH, Takahashi R, Misawa H, Cleveland DW (2008) Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci 11(3):251–253
Chio A, Calvo A, Mazzini L, Cantello R, Mora G, Moglia C, Corrado L, D’Alfonso S, Majounie E, Renton A, Pisano F, Ossola I, Brunetti M, Traynor BJ, Restagno G, Parals (2012) Extensive genetics of ALS: a population-based study in Italy. Neurology 79(19):1983–1989. https://doi.org/10.1212/WNL.0b013e3182735d36
Talbott EO, Malek AM, Lacomis D (2016) The epidemiology of amyotrophic lateral sclerosis. Handb Clin Neurol 138:225–238. https://doi.org/10.1016/B978-0-12-802,973-2.00013-6
Takeuchi R, Tada M, Shiga A, Toyoshima Y, Konno T, Sato T, Nozaki H, Kato T, Horie M, Shimizu H, Takebayashi H, Onodera O, Nishizawa M, Kakita A, Takahashi H (2016) Heterogeneity of cerebral TDP-43 pathology in sporadic amyotrophic lateral sclerosis: evidence for clinico-pathologic subtypes. Acta Neuropathologica Commun 4(1):61. https://doi.org/10.1186/s40478-016-0335-2
Strong MJ, Abrahams S, Goldstein LH, Woolley S, McLaughlin P, Snowden J, Mioshi E, Roberts-South A, Benatar M, HortobaGyi T, Rosenfeld J, Silani V, Ince PG, Turner MR (2017) Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria. Amyotroph Lateral Scler Frontotempl Degen 18(3–4):153–174. https://doi.org/10.1080/21678421.2016.1267768
Henstridge CM, Sideris DI, Carroll E, Rotariu S, Salomonsson S, Tzioras M, McKenzie C-A, Smith C, von Arnim CAF, Ludolph AC, Lule D, Leighton D, Warner J, Cleary E, Newton J, Swingler R, Chandran S, Gillingwater TH, Abrahams S, Spires-Jones TL (2018) Synapse loss in the prefrontal cortex is associated with cognitive decline in amyotrophic lateral sclerosis. Acta Neuropathol 135(2):213–226
Pamphlett R, Kum Jew S (2013) Uptake of inorganic mercury by human locus ceruleus and corticomotor neurons: implications for amyotrophic lateral sclerosis. Acta Neuropathologica Commun 1:13
Chuu J-J, Liu S-H, Lin-Shiau S-Y (2007) Differential neurotoxic effects of methylmercury and mercuric sulfide in rats. Toxicol Lett 169(2):109–120
Praline J, Guennoc AM, Limousin N, Hallak H, de Toffol B, Corcia P (2007) ALS and mercury intoxication: a relationship? Clin Neurol Neurosurg 109(10):880–883. https://doi.org/10.1016/j.clineuro.2007.07.008
Mangelsdorf I, Walach H, Mutter J (2017) Healing of amyotrophic lateral sclerosis: a case report. Complement Med Res 24(3):175–181. https://doi.org/10.1159/000477397
Kotelnikova E, Kiani NA, Abad E, Martinez-Lapiscina EH, Andorra M, Zubizarreta I, Pulido-Valdeolivas I, Pertsovskaya I, Alexopoulos LG, Olsson T, Martin R, Paul F, Tegner J, Garcia-Ojalvo J, Villoslada P (2017) Dynamics and heterogeneity of brain damage in multiple sclerosis. PLoS Comput Biol 13(10):e1005757. https://doi.org/10.1371/journal.pcbi.1005757
Leray E, Moreau T, Fromont A, Edan G (2016) Epidemiology of multiple sclerosis. Rev Neurol 172(1):3–13. https://doi.org/10.1016/j.neurol.2015.10.006
Crabtree-Hartman E (2018) Advanced symptom management in multiple sclerosis. Neurol Clin 36 (1):197-+. https://doi.org/10.1016/j.ncl.2017.08.015
Patsopoulos NA (2018) Genetics of multiple sclerosis: an overview and new directions. Cold Spring Harbor perspectives in medicine doi:https://doi.org/10.1101/cshperspect.a028951
Visconti A, Cotichini R, Cannoni S, Bocca B, Forte G, Ghazaryan A, Santucci S, D’Ippolito C, Stazi MA, Salvetti M, Alimonti A, Ristori G (2005) Concentration of elements in serum of patients affected by multiple sclerosis with first demyelinating episode: a six-month longitudinal follow-up study. Annali dell’Istituto Superiore di Sanita 41(2):217–222
Attar AM, Kharkhaneh A, Etemadifar M, Keyhanian K, Davoudi V, Saadatnia M (2012) Serum mercury level and multiple sclerosis. Biol Trace Elem Res 146(2):150–153. https://doi.org/10.1007/s12011-011-9239-y
Dulamea AO, Boscaiu V, Sava MM (2015) Disability status and dental pathology in multiple sclerosis patients. Mult Scler Relat Disord 4(6):567–571. https://doi.org/10.1016/j.msard.2015.09.001
Casetta I, Invernizzi M, Granieri E (2001) Multiple sclerosis and dental amalgam: case-control study in Ferrara, Italy. Neuroepidemiology 20(2):134–137. https://doi.org/10.1159/000054773
Bates MN, Fawcett J, Garrett N, Cutress T, Kjellstrom T (2004) Health effects of dental amalgam exposure: a retrospective cohort study. Int J Epidemiol 33(4):894–902. https://doi.org/10.1093/ije/dyh164
Ceccatelli S, Dare E, Moors M (2010) Methylmercury-induced neurotoxicity and apoptosis. Chem Biol Interact 188(2):301–308. https://doi.org/10.1016/j.cbi.2010.04.007
Kakita A, Wakabayashi K, Su M, Yoneoka Y, Sakamoto M, Ikuta F, Takahashi H (2000) Intrauterine methylmercury intoxication. Consequence of the inherent brain lesions and cognitive dysfunction in maturity. Brain Res 877(2):322–330
Sakaue M, Mori N, Makita M, Fujishima K, Hara S, Arishima K, Yamamoto M (2009) Acceleration of methylmercury-induced cell death of rat cerebellar neurons by brain-derived neurotrophic factor in vitro. Brain Res 1273:155–162. https://doi.org/10.1016/j.brainres.2009.03.035
Yee S, Choi BH (1996) Oxidative stress in neurotoxic effects of methylmercury poisoning. Neurotoxicology 17(1):17–26
Shanker G, Aschner JL, Syversen T, Aschner M (2004) Free radical formation in cerebral cortical astrocytes in culture induced by methylmercury. Brain Res Mol Brain Res 128(1):48–57. https://doi.org/10.1016/j.molbrainres.2004.05.022
Aschner M, Allen JW (2000) Astrocytes in methylmercury, ammonia, methionine sulfoximine and alcohol-induced neurotoxicity. Neurotoxicology 21(4):573–579
Ramanathan G, Atchison WD (2011) Ca2+ entry pathways in mouse spinal motor neurons in culture following in vitro exposure to methylmercury. Neurotoxicology 32(6):742–750. https://doi.org/10.1016/j.neuro.2011.07.007
Amonpatumrat S, Sakurai H, Wiriyasermkul P, Khunweeraphong N, Nagamori S, Tanaka H, Piyachaturawat P, Kanai Y (2008) L-glutamate enhances methylmercury toxicity by synergistically increasing oxidative stress. J Pharmacol Sci 108(3):280–289
Wang X, Yan M, Zhao L, Wu Q, Wu C, Chang X, Zhou Z (2016) Low-dose methylmercury-induced apoptosis and mitochondrial DNA mutation in human embryonic neural progenitor cells. Oxidative Med Cell Longev 2016:5137042. https://doi.org/10.1155/2016/5137042
Szumanska G, Gadamski R, Albrecht J (1993) Changes of the Na/K ATPase activity in the cerebral cortical microvessels of rat after single intraperitoneal administration of mercuric chloride: histochemical demonstration with light and electron microscopy. Acta Neuropathol 86(1):65–70
Teixeira FB, Fernandes RM, Farias PMA, Costa NMM, Fernandes LMP, Santana LNS, Silva AF, Silva MCF, Maia CSF, Lima RR (2014) Evaluation of the effects of chronic intoxication with inorganic mercury on memory and motor control in rats. Int J Env Res Pub He 11(9):9171–9185. https://doi.org/10.3390/ijerph110909171
Goering PL, Morgan DL, Ali SF (2002) Effects of mercury vapor inhalation on reactive oxygen species and antioxidant enzymes in rat brain and kidney are minimal. J Appl Toxicol: JAT 22(3):167–172. https://doi.org/10.1002/jat.844
Cooper JF, Kusnecov AW (2007) Methylmercuric chloride induces activation of neuronal stress circuitry and alters exploratory behavior in the mouse. Neuroscience 148(4):1048–1064. https://doi.org/10.1016/j.neuroscience.2007.07.034
Rice D, Barone S Jr (2000) Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect 108(Suppl 3):511–533
Manfroi CB, Schwalm FD, Cereser V, Abreu F, Oliveira A, Bizarro L, Rocha JBT, Frizzo MES, Souza DO, Farina M (2004) Maternal milk as methylmercury source for suckling mice: neurotoxic effects involved with the cerebellar glutamatergic system. Toxicol Sci 81(1):172–178. https://doi.org/10.1093/toxsci/kfh201
Sakamoto M, Kakita A, Wakabayashi K, Takahashi H, Nakano A, Akagi H (2002) Evaluation of changes in methylmercury accumulation in the developing rat brain and its effects: a study with consecutive and moderate dose exposure throughout gestation and lactation periods. Brain Res 949(1–2):51–59
Antonelli MC, Pallares ME, Ceccatelli S, Spulber S (2017) Long-term consequences of prenatal stress and neurotoxicants exposure on neurodevelopment. Prog Neurobiol 155:21–35. https://doi.org/10.1016/j.pneurobio.2016.05.005
Boomhower SR, Newland MC (2016) Adolescent methylmercury exposure affects choice and delay discounting in mice. Neurotoxicology 57:136–144. https://doi.org/10.1016/j.neuro.2016.09.016
Pope DA, Newland MC, Hutsell BA (2015) Delay-specific stimuli and genotype interact to determine temporal discounting in a rapid-acquisition procedure. J Exp Anal Behav 103(3):450–471. https://doi.org/10.1002/jeab.148
Fujimura M, Usuki F (2017) In situ different antioxidative systems contribute to the site-specific methylmercury neurotoxicity in mice. Toxicology 392:55–63. https://doi.org/10.1016/j.tox.2017.10.004
Fujimura M, Usuki F (2017) Site-specific neural hyperactivity via the activation of MAPK and PKA/CREB pathways triggers neuronal degeneration in methylmercury-intoxicated mice. Toxicol Lett 271:66–73. https://doi.org/10.1016/j.toxlet.2017.03.001
Agrawal M, Bhaskar AS, Lakshmana Rao PV (2015) Involvement of mitogen-activated protein kinase pathway in T-2 toxin-induced cell cycle alteration and apoptosis in human neuroblastoma cells. Mol Neurobiol 51(3):1379–1394. https://doi.org/10.1007/s12035-014-8816-4
Venkatesan RS, Sadiq AM (2017) Effect of morin-5′-sulfonic acid sodium salt on the expression of apoptosis related proteins caspase 3, Bax and Bcl 2 due to the mercury induced oxidative stress in albino rats. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 85:202–208. https://doi.org/10.1016/j.biopha.2016.09.090
Shen AN, Cummings C, Hoffman D, Pope D, Arnold M, Newland MC (2016) Aging, motor function, and sensitivity to calcium channel blockers: an investigation using chronic methylmercury exposure. Behav Brain Res 315:103–114. https://doi.org/10.1016/j.bbr.2016.07.049
Funding
This work was supported by the current research funds 2018 of IRCCS “Centro Neurolesi Bonino Pulejo.”
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cariccio, V.L., Samà, A., Bramanti, P. et al. Mercury Involvement in Neuronal Damage and in Neurodegenerative Diseases. Biol Trace Elem Res 187, 341–356 (2019). https://doi.org/10.1007/s12011-018-1380-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12011-018-1380-4